Latest Breaking News On - Clin psychopharmacol - Page 1 : comparemela.com

Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U S FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)

U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular monoamine transporter 2 inhibitor for effective.

United statesDell faulkinghamRakesh jainClin psychopharmacolNational institute of mental healthTexas tech university school of medicineDrug administrationTeva shared solutionsTeva neuroscience incTeva pharmaceutical industries ltdUnderstanding how chorea affects healthUs department of healthHuman servicesOnline survey of patientsNational institute of neurological disordersTeva pharmaceuticals

Exxua: A Lengthy Approval Under a Regulatory Lens

Exxua: A Lengthy Approval Under a Regulatory Lens
pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesClin psychopharmacolKaur gillMead johnsonBristol myers squibbFabre kramer phaemaceuticalsPsychopharmacologic drugs advisory committee meetingPsychopharmacologic drugs advisory committeeFabre kramer pharmaceuticals announcesEuropean medicines agencyFabre kramer pharmaceuticalsIntj health servDrug administrationBristol myers companyNew york times

Tardive Dyskinesia in US Antipsychotic Users

This 2024 APA Annual Meeting poster estimated the prevalence of tardive dyskinesia in antipsychotic users in the US, and found rates ranging from 94.1-127.4 per 1000 antipsychotic users.

United statesNew yorkClin psychopharmacolRichelle adobestockCenters for medicare medicaid servicesAmerican psychiatric association annual meetingUnited states aboutPsychiatric association annual meetingTardive dyskinesia prevalenceAntipsychotic usersMedicaid servicesMayo clinicBipolar disorder biobank

Long-acting injectable antipsychotics lower hospital readmission rates for schizophrenia

Long-acting injectable antipsychotics lower hospital readmission rates for schizophrenia
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Pragya thamanClin psychopharmacolShenaz baghaBysara kellnerInvega sustennaJohnson global medical affairs oncologyJohnson global medical affairs oncology fellow

Clinicians Use SSRIs Off- Label in Many Conditions

As the body of data has grown, clinicians’ propensity to use selective serotonin reuptake inhibitors off-label has increased

United statesJeannettey wickClin psychopharmacolEli lillyAshinam serotonergicGastroenterol hepatolAmerican headache societyJazz pharmaceuticalsUniversity of connecticut school pharmacyAmerican psychiatric associationOffice of pharmacy professional developmentAmerican psychiatric association publishingWorld federation of societies biological psychiatryAmerican academy of neurologyAmerican academyWorld federation